# A Case-Control Study of Continuous Veno-Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis

Authors: Yan Liu; Bing Wang; Qian Zhang; Yuliang Zhao; Xudong Wang
Journal: Contrast Media & Molecular Imaging
 (2022)

---

## Abstract

A case-control study was conducted to evaluate the efficacy of continuous veno-venous hemofiltration (CVVH) combined with Xuebijing in the treatment of severe sepsis. In order to verify this claim, this study included 100 patients with severe sepsis treated in our hospital from February 2019 to April 2021. The patients were randomly divided into control group and study group. The control group was treated with CVVH, and the study group was treated with CVVH combined with Xuebijing. The curative effect and mortality, NT-proBNP, PCT, Ca∼_(2+), white blood cell count, neutrophil ratio, blood gas analysis, and APACHE-II score were compared between the two groups. The total effective rate of the study group was better than that of the control groupP<0.05. The fatality rate in the study group was lower than that in the control group P<0.05. The levels of NT-proBNP and PCT in the study group were lower than those in the control group, while the level of serum calcium in the study group was higher than that in the control group. After treatment, the white blood cell count (WBC) and neutrophil count in the study group were (13.76 ± 1.28) × 109 shock L and (73.48 ± 1.23)%, respectively, which were significantly lower than those in the control group (17.45 ± 1.36) × 109 shock L and (77.82 ± 1.44)% P<0.05. After treatment, the levels of APTT, PT, and DD in the study group were lower than those in the control group. The level of FIB in the study group was significantly higher than that in the control group after treatment. After treatment, the PaO2 and PaO2/FiO2 of the study group were higher than those of the control group, and the APACHE-II score of the study group was lower than that of the control group. CVVH combined with Xuebijing is of positive significance in the treatment of severe sepsis and is worth popularizing.


---

## Body

## 1. Introduction

Sepsis is a disease that seriously threatens people’s lives [1]. The incidence of multiple organ dysfunction syndrome induced by sepsis has increased by about 137% in the past decade, and the incidence of secondary acute renal failure (ARF) in patients with sepsis is 48%, the fatality rate is 73%, and once secondary ARF medical costs will significantly increase, so early prevention and treatment of renal failure is a very urgent [2–4]. At present, it is believed that the common pathophysiological feature of critically ill patients caused by sepsis is that a series of inflammatory cells such as monocytes, macrophages, and endothelial cells have been activated and a large number of pro-inflammatory cells have been released. Mediators show a “waterfall effect,” resulting in excessive release of inflammatory factors, such as tumor necrosis factor, interleukin-6, interleukin-8, and so on [5]. It has been reported that when the body is seriously infected, endotoxin binds to the endotoxin binding protein in the blood to form a complex, which transmits the signal from the receptor to the nucleus through the cellular signal transduction mechanism. Finally, it can cause renal microvascular dysfunction, endothelial injury, and increased permeability, resulting in poor renal perfusion, abnormal renal blood flow distribution, glomerular capillary microthrombosis, and direct or indirect damage to renal tissue cells and promote renal tubule and glomerular dysfunction and structural damage [6]. Traditional Chinese medicine believes that the disease belongs to the category of “febrile disease.” The patient feels evil poison externally, and the body defense qi is not enough to render the evil toxin to invade the viscera from the outside to the inside; the internal toxin of the viscera grows so that the internal and external organs are trapped, the organs are trapped and lose their duty, and the meridian loses its qi and stasis, leading to febrile disease [7]. Xuebijing is a pure traditional Chinese medicine preparation, which is effective in the treatment of all kinds of infectious diseases. Chang Wenxiu and other studies found that Xuebijing can quickly reduce the amount of blood bacteria in patients, and the amount of blood bacteria in patients decreased by 97% after one week of medication, which is related to the fact that the drug contains a variety of antibacterial ingredients. Xuebijing injection is an empirical prescription screened and summarized by Professor Wang Jinda on the basis of Xuefu Zhuyu decoction, which has been proved by modern medical research [7]. Xuebijing has the effects of antagonizing endotoxin, protecting endothelial cells, improving microcirculation, regulating immune response, and correcting the disorder of blood coagulation and can block the occurrence and development of sepsis. Some scholars have found that inflammatory mediators play an important role in the pathogenesis of sepsis. Continuous veno-venous hemofiltration (CVVH) can remove the excessive release of inflammatory mediators in circulation and improve the prognosis of patients [8]. Therefore, the purpose of this study was to analyze the application value of CVVH combined with Xuebijing in the treatment of severe sepsis.A case-control study was conducted to evaluate efficacy of the continuous veno-venous hemofiltration (CVVH) combined with Xuebijing in the treatment of severe sepsis. To check or verify this claim, a total of 100 patients with severe sepsis treated in our hospital, specifically from February 2019 to April 2021, were enrolled in this study. The patients were randomly divided into control group and study group. The control group was treated with CVVH, and the study group was treated with CVVH combined with Xuebijing. The therapeutic effect and mortality, NT-proBNP, PCT and Ca2+, white blood cell count, neutrophil ratio, blood gas analysis, and APACHE-II score were compared between the two groups. There was no statistical difference in baseline clinical data between the two kinds of patients. In the comparison of the treatment effects between the two groups, there were 27 cases of markedly effective, 22 cases of effective, and 1 case of ineffective in the study group, and the total effective rate was 98%; in the control group, 15 cases were markedly effective, 28 cases were effective, and 13 cases were ineffective, and the total effective rate was 86% P<0.05.The rest of the manuscript is arranged as given below.In the following sections, the proposed method and as much detailed information as possible, such as the selection and rejection criteria of patients willing to participate in this trial setting, will be described in detail. The results of theexperimental device verify the proposed scheme requirements and provide sufficient detailed information in Section3 of this manuscript. A general discussion section was provided, followed by the concluding observations of the last part.


## 2. Proposed Method

### 2.1. General Information

A total of 100 patients with severe sepsis were selected from February 2019 to April 2021. The patients were randomly divided into the control group and the study group. In the control group, the age was 43–74 years old, with an average of (65.91 ± 3.63) years, including 28 males and 22 females, while in the study group, the age was 44–76 years old, with an average of (65.96 ± 3.58) years, including 26 males and 24 females. There was no statistical significance in the general data of the two groups. This study was approved by the Medical Ethics Association of our hospital, and all patients signed informed consent.The inclusion criteria were as follows:(1)
Age was ≥18 years old;(2)
The patients had good communication skills and no language barrier, so they could actively cooperate with the relevant scores, examinations, and inquiries;(3)
The routine laboratory indexes were not abnormal before operation; and(4)
They met the diagnostic criteria of severe sepsis.The exclusion criteria were as follows:(1)
Patients with severe heart, liver, renal insufficiency, malignant tumors, and other diseases;(2)
Patients with long-term infection or recent infection not cured after treatment, or infection has been cured for less than one year;(3)
Patients with coagulation dysfunction.


### 2.2. Intervention Methods

The control group was treated with CVVH, and the methods were as follows: internal jugular vein or femoral vein double lumen catheter was used as vascular pathway; HP used HA330 blood adsorption irrigator produced by Zhuhai Jianfan Biotechnology, 2 hours before continuous blood purification; CVVH used replacement fluid flow 2∼4 L/h, blood flow 200 mL/min, and low molecular weight heparin for anticoagulants. After 2 hours, the perfusion device was removed by air method, and hemofiltration continued for 24 hours. The average treatment time was 3 days, and the treatment time was prolonged appropriately according to the related indexes of renal function such as creatinine, urea nitrogen, and urine volume in patients with chronic renal insufficiency. On this basis, the study group was combined with Xuebijing injection (Tianjin Hongri Pharmaceutical Co., Ltd.) 50 ml intravenous drip, twice a day for 7 days, while LMWH (Sanofi Aventis (China) Investment 0.3–0.6 ml was subcutaneously injected once a day for 7 days.


### 2.3. Observation Index

#### 2.3.1. Evaluation of Curative Effect and Mortality

The standard of therapeutic effect refers to the “Therapeutic effect Standard of Disease and Syndrome diagnosis of traditional Chinese Medicine” [9](1)
significant effect: 70% ≤symptom reduction rate;(2)
effective: 30% ≤symptom frivolity <70% Shi;(3)
ineffective: symptom reduction rate <30%.


#### 2.3.2. Laboratory Examination Method

Ca2+ was detected by Kemenkul 400 automatic biochemical analyzer made in Germany (transmission turbidimetry and constant speed 400 percussion h). The levels of N-terminal B-type natriuretic peptide (NT-proBNP) and procalcitonin (PCT) were detected by enzyme-linked immunosorbent assay (SB enzyme labeling instrument of Roche, Switzerland; NT-proBNP ELISA kit: 96T∼201423∼x PCT ELISA kit: specification 96T∼201423). White blood cell count and neutrophils were detected by blood cell analyzer (Shenzhen Kubel Biotechnology Co., Ltd., us = 2200).


#### 2.3.3. Examination Method of Blood Coagulation Function Index

Before treatment and 7 days after treatment, venous blood 5 ml was extracted from empty stock in the morning, and the supernatant was taken after centrifugation and stored at -209C. Activated partial thromboplastin time (APTT), prothrombin time (PT), and fibrinogen (FIB) were detected by Japanese Sysmex CA-4500 coagulation instrument, and plasma D-dimer (DD) was detected by Norwegian NycoCard READER II gold standard method.


#### 2.3.4. Methods of Blood Gas Examination Such as Partial Pressure of Oxygen (PaO2) and Oxygenation Index (PaO2/FiO2)

Arterial blood samples were taken to detect blood gas analysis and record PaO2 and PaO2/FiO2. Oxygenation index is an important index to evaluate the respiratory function of patients. When oxygenation index is lower than 200, patients have acute lung injury. If oxygenation index is lower than 150, patients have acute respiratory distress syndrome.


#### 2.3.5. APACHE-II Scoring

APACHE-II score consists of acute physiology score, age score, and chronic health score. The higher the score, the worse the condition, the worse the prognosis, and the higher the fatality rate; the acute physiological score (APS) includes 12 physiological indexes, and the worst value (the highest or lowest value) within the first 24 hours of ICU is selected to score, and the higher score is chosen; the age score is divided into 5 stages from 44 to 75 years old, which are rated as 02jue, 3jue, 5pm, and 6, respectively. Chronic health score requires patients to meet the diagnosis of chronic organ insufficiency or immunosuppression before admission. Patients with chronic organ insufficiency or immunosuppression should be admitted into ICU after elective operation and 5 points after emergency operation or nonoperation, and the final APACHE-II score is the sum of three scores.


### 2.4. Statistical Analysis

SPSS 21.0 statistical software was used to collate and analyze the data. Takingn (%) to represent the counting data, χ2 test was adopted, and t-test was used for comparison between groups. At P<0.05, the difference was statistically significant.


## 2.1. General Information

A total of 100 patients with severe sepsis were selected from February 2019 to April 2021. The patients were randomly divided into the control group and the study group. In the control group, the age was 43–74 years old, with an average of (65.91 ± 3.63) years, including 28 males and 22 females, while in the study group, the age was 44–76 years old, with an average of (65.96 ± 3.58) years, including 26 males and 24 females. There was no statistical significance in the general data of the two groups. This study was approved by the Medical Ethics Association of our hospital, and all patients signed informed consent.The inclusion criteria were as follows:(1)
Age was ≥18 years old;(2)
The patients had good communication skills and no language barrier, so they could actively cooperate with the relevant scores, examinations, and inquiries;(3)
The routine laboratory indexes were not abnormal before operation; and(4)
They met the diagnostic criteria of severe sepsis.The exclusion criteria were as follows:(1)
Patients with severe heart, liver, renal insufficiency, malignant tumors, and other diseases;(2)
Patients with long-term infection or recent infection not cured after treatment, or infection has been cured for less than one year;(3)
Patients with coagulation dysfunction.


## 2.2. Intervention Methods

The control group was treated with CVVH, and the methods were as follows: internal jugular vein or femoral vein double lumen catheter was used as vascular pathway; HP used HA330 blood adsorption irrigator produced by Zhuhai Jianfan Biotechnology, 2 hours before continuous blood purification; CVVH used replacement fluid flow 2∼4 L/h, blood flow 200 mL/min, and low molecular weight heparin for anticoagulants. After 2 hours, the perfusion device was removed by air method, and hemofiltration continued for 24 hours. The average treatment time was 3 days, and the treatment time was prolonged appropriately according to the related indexes of renal function such as creatinine, urea nitrogen, and urine volume in patients with chronic renal insufficiency. On this basis, the study group was combined with Xuebijing injection (Tianjin Hongri Pharmaceutical Co., Ltd.) 50 ml intravenous drip, twice a day for 7 days, while LMWH (Sanofi Aventis (China) Investment 0.3–0.6 ml was subcutaneously injected once a day for 7 days.


## 2.3. Observation Index

### 2.3.1. Evaluation of Curative Effect and Mortality

The standard of therapeutic effect refers to the “Therapeutic effect Standard of Disease and Syndrome diagnosis of traditional Chinese Medicine” [9](1)
significant effect: 70% ≤symptom reduction rate;(2)
effective: 30% ≤symptom frivolity <70% Shi;(3)
ineffective: symptom reduction rate <30%.


### 2.3.2. Laboratory Examination Method

Ca2+ was detected by Kemenkul 400 automatic biochemical analyzer made in Germany (transmission turbidimetry and constant speed 400 percussion h). The levels of N-terminal B-type natriuretic peptide (NT-proBNP) and procalcitonin (PCT) were detected by enzyme-linked immunosorbent assay (SB enzyme labeling instrument of Roche, Switzerland; NT-proBNP ELISA kit: 96T∼201423∼x PCT ELISA kit: specification 96T∼201423). White blood cell count and neutrophils were detected by blood cell analyzer (Shenzhen Kubel Biotechnology Co., Ltd., us = 2200).


### 2.3.3. Examination Method of Blood Coagulation Function Index

Before treatment and 7 days after treatment, venous blood 5 ml was extracted from empty stock in the morning, and the supernatant was taken after centrifugation and stored at -209C. Activated partial thromboplastin time (APTT), prothrombin time (PT), and fibrinogen (FIB) were detected by Japanese Sysmex CA-4500 coagulation instrument, and plasma D-dimer (DD) was detected by Norwegian NycoCard READER II gold standard method.


### 2.3.4. Methods of Blood Gas Examination Such as Partial Pressure of Oxygen (PaO2) and Oxygenation Index (PaO2/FiO2)

Arterial blood samples were taken to detect blood gas analysis and record PaO2 and PaO2/FiO2. Oxygenation index is an important index to evaluate the respiratory function of patients. When oxygenation index is lower than 200, patients have acute lung injury. If oxygenation index is lower than 150, patients have acute respiratory distress syndrome.


### 2.3.5. APACHE-II Scoring

APACHE-II score consists of acute physiology score, age score, and chronic health score. The higher the score, the worse the condition, the worse the prognosis, and the higher the fatality rate; the acute physiological score (APS) includes 12 physiological indexes, and the worst value (the highest or lowest value) within the first 24 hours of ICU is selected to score, and the higher score is chosen; the age score is divided into 5 stages from 44 to 75 years old, which are rated as 02jue, 3jue, 5pm, and 6, respectively. Chronic health score requires patients to meet the diagnosis of chronic organ insufficiency or immunosuppression before admission. Patients with chronic organ insufficiency or immunosuppression should be admitted into ICU after elective operation and 5 points after emergency operation or nonoperation, and the final APACHE-II score is the sum of three scores.


## 2.3.1. Evaluation of Curative Effect and Mortality

The standard of therapeutic effect refers to the “Therapeutic effect Standard of Disease and Syndrome diagnosis of traditional Chinese Medicine” [9](1)
significant effect: 70% ≤symptom reduction rate;(2)
effective: 30% ≤symptom frivolity <70% Shi;(3)
ineffective: symptom reduction rate <30%.


## 2.3.2. Laboratory Examination Method

Ca2+ was detected by Kemenkul 400 automatic biochemical analyzer made in Germany (transmission turbidimetry and constant speed 400 percussion h). The levels of N-terminal B-type natriuretic peptide (NT-proBNP) and procalcitonin (PCT) were detected by enzyme-linked immunosorbent assay (SB enzyme labeling instrument of Roche, Switzerland; NT-proBNP ELISA kit: 96T∼201423∼x PCT ELISA kit: specification 96T∼201423). White blood cell count and neutrophils were detected by blood cell analyzer (Shenzhen Kubel Biotechnology Co., Ltd., us = 2200).


## 2.3.3. Examination Method of Blood Coagulation Function Index

Before treatment and 7 days after treatment, venous blood 5 ml was extracted from empty stock in the morning, and the supernatant was taken after centrifugation and stored at -209C. Activated partial thromboplastin time (APTT), prothrombin time (PT), and fibrinogen (FIB) were detected by Japanese Sysmex CA-4500 coagulation instrument, and plasma D-dimer (DD) was detected by Norwegian NycoCard READER II gold standard method.


## 2.3.4. Methods of Blood Gas Examination Such as Partial Pressure of Oxygen (PaO2) and Oxygenation Index (PaO2/FiO2)

Arterial blood samples were taken to detect blood gas analysis and record PaO2 and PaO2/FiO2. Oxygenation index is an important index to evaluate the respiratory function of patients. When oxygenation index is lower than 200, patients have acute lung injury. If oxygenation index is lower than 150, patients have acute respiratory distress syndrome.


## 2.3.5. APACHE-II Scoring

APACHE-II score consists of acute physiology score, age score, and chronic health score. The higher the score, the worse the condition, the worse the prognosis, and the higher the fatality rate; the acute physiological score (APS) includes 12 physiological indexes, and the worst value (the highest or lowest value) within the first 24 hours of ICU is selected to score, and the higher score is chosen; the age score is divided into 5 stages from 44 to 75 years old, which are rated as 02jue, 3jue, 5pm, and 6, respectively. Chronic health score requires patients to meet the diagnosis of chronic organ insufficiency or immunosuppression before admission. Patients with chronic organ insufficiency or immunosuppression should be admitted into ICU after elective operation and 5 points after emergency operation or nonoperation, and the final APACHE-II score is the sum of three scores.


## 2.4. Statistical Analysis

SPSS 21.0 statistical software was used to collate and analyze the data. Takingn (%) to represent the counting data, χ2 test was adopted, and t-test was used for comparison between groups. At P<0.05, the difference was statistically significant.


## 3. Experimental Results and Observations

### 3.1. Comparison of Therapeutic Effects

The therapeutic effects are an important observation index in this study, so first of all, we compared the curative effect between the two groups. The therapeutic effects of the two groups were compared. In the study group, 27 cases were markedly effective, 22 cases were effective, and 1 case was ineffective. The total effective rate was 98.00%. In the control group, 15 cases were markedly effective, 28 cases were effective, and 13 cases were ineffective. The total effective rate was 86.00%. The total effective rate of the study group was higher than that of the control group, and the difference was statistically significantP<0.05. All the data results are shown in Table 1.Table 1
Comparison of therapeutic effects between the two groups[n/%].
GroupNSignificant effectEffectiveInvalidTotal efficiencyC group5015 (30.00)28 (56.00)7 (14.00)43 (86.00)R group5027 (54.00)22 (44.00)1 (2.00)49 (98.00)χ24.891P0.026


### 3.2. Comparison of Case Fatality Rate between the Two Groups

The case fatality rate is an important observation index in this study, so we compared the case fatality rate between the two groups. The case fatality rate of the two groups was compared: 1 case of the study group died after treatment, the case fatality rate was 2.00%; 7 cases of the control group died after treatment, the case fatality rate was 14.00%; the case fatality rate of the study group was lower than that of the control group, and there was significant difference between the two groups (χ2-4.891; P<0.05).


### 3.3. Comparison of NT-proBNP, PCT, and Ca2+ between the Two Groups after Treatment

NT-proBNP, PCT, and Ca2+ are important observation indexes in this study, so we compared NT-proBNP, PCT, and Ca2+ between the two groups. We compared the levels of NT-proBNP, PCT, and Ca2+ between the two groups after treatment. After treatment, the levels of NT-proBNP and PCT in the study group were significantly lower than those in the control group, and the content of serum Ca2+ in the study group was significantly higher than that in the control group. All the data results are shown in Table 2.Table 2
Comparison of NT-proBNP, PCT, and Ca2+ after treatment x¯±s.
GroupNNT-proBNP (ng/L)PCT (μg/L)Serum Ca2+ (mmol/L)C group501722.53 ± 198.4114.52 ± 3.201.42 ± 0.45R group501057.47 ± 165.607.38 ± 2.322.23 ± 0.72t18.19712.7736.746P0.0000.0000.000


### 3.4. Comparison of White Blood Cell Count and Neutrophil Ratio

We compared the white blood cell count and neutrophil ratio, and there was no significant difference between the two groups before treatmentP>0.05. The white blood cell count and neutrophil ratio in the study group were lower than those in the control group, and the difference was statistically significant P<0.05. The white blood cell count and the proportion of neutrophils in the study group were significantly lower than those in the control group P<0.05. All the data results are shown in Table 3.Table 3
Comparison of leukocyte count and neutrophil ratio B before and after treatment [x¯±s, Points].
GroupNWhite blood cell count (×109/L)Neutrophil ratio (%)Before treatmentAfter treatmentBefore treatmentAfter treatmentC group5022.63 ± 2.1217.45 ± 1.36a81.56 ± 2.7477.82 ± 1.44aR group5022.46 ± 2.1413.76 ± 1.28b81.17 ± 2.5673.48 ± 1.23bt0.39913.9710.73516.205P0.6910.0000.4640.000Note. the control group before and after treatment, aP<0.05; the study group before and after treatment, bP<0.05.


### 3.5. Comparison of Blood Coagulation Function Indexes between the Two Groups before and after Treatment

We compared the indexes of blood coagulation function between the two groups before and after treatment. Before treatment, there was no significant difference in the levels of APTT, PT, FIB, and DD between the two groups. After treatment, the levels of APTT, PT, and DD in the two groups decreased continuously, while the levels of FIB increased. Compared with the control group, the levels of APTT, PT, and DD in the study group were lower than those in the control group, while the level of FIB in the study group was higher than that in the control groupP<0.05. All the data are shown in Table 4.Table 4
Comparison of blood coagulation function indexes between the two groups before and after treatments (x¯±s, n = 50).
GroupAPTT (s)PT (s)FIB (g/L)DD (μg/L)Before treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatmentC group46.15 ± 9.4142.42 ± 8.44a14.97 ± 3.6213.29 ± 2.71a1.85 ± 0.432.56 ± 0.53a1354.59 ± 420.621024.47 ± 308.08aR group46.34 ± 9.3638.25 ± 8.37b14.37 ± 3.5612.18 ± 2.30b1.79 ± 0.543.78 ± 0.44b1350.55 ± 417.57790.33 ± 310.24bt Value0.1012.4810.8362.2080.61512.5240.0423.787P value0.9200.0150.4050.0300.5400.0000.9620.000Note. the control group before and after treatment, aP<0.05; the study group before and after treatment, bP<0.05.


### 3.6. Comparison of Blood Gas Analysis and APACHE-II Score between the Two Groups before and after Treatment

We compared the blood gas analysis and APACHE-II score between the two groups before and after treatment. There was no significant difference in partial pressure of oxygen (PaO2), oxygenation index (PaO2/FiO2), and APACHE-II score between the two groups before treatment. Compared with those before treatment, PaO2 and (PaO2/FiO2) increased and APACHE-II score decreased in both groups after treatment. Compared with the control group, PaO2 and PaO2/FiO2 were significantly higher and APACHE-II scores were lower in the treatment group after treatment. All the data are shown in Table 5.Table 5
Comparison of blood gas analysis and APACHE-II score before and after treatment (x¯±s, n = 50).
GroupPaO2 (mmHg)PaO2/FiO2APACHE-II Scoring (Points)Before treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatmentC group72.41 ± 12.0591.44 ± 10.30a206.55 ± 22.58313.55 ± 25.37a23.46 ± 3.3117.58 ± 3.11aR group72.38 ± 12.1196.82 ± 10.29b207.43 ± 23.15342.72 ± 26.10b23.50 ± 3.4213.37 ± 2.85bt0.0122.6130.1925.6670.0597.057P0.9900.0100.8480.0000.9530.000Note. the control group before and after treatment, aP<0.05; the study group before and after treatment, bP<0.05.


## 3.1. Comparison of Therapeutic Effects

The therapeutic effects are an important observation index in this study, so first of all, we compared the curative effect between the two groups. The therapeutic effects of the two groups were compared. In the study group, 27 cases were markedly effective, 22 cases were effective, and 1 case was ineffective. The total effective rate was 98.00%. In the control group, 15 cases were markedly effective, 28 cases were effective, and 13 cases were ineffective. The total effective rate was 86.00%. The total effective rate of the study group was higher than that of the control group, and the difference was statistically significantP<0.05. All the data results are shown in Table 1.Table 1
Comparison of therapeutic effects between the two groups[n/%].
GroupNSignificant effectEffectiveInvalidTotal efficiencyC group5015 (30.00)28 (56.00)7 (14.00)43 (86.00)R group5027 (54.00)22 (44.00)1 (2.00)49 (98.00)χ24.891P0.026


## 3.2. Comparison of Case Fatality Rate between the Two Groups

The case fatality rate is an important observation index in this study, so we compared the case fatality rate between the two groups. The case fatality rate of the two groups was compared: 1 case of the study group died after treatment, the case fatality rate was 2.00%; 7 cases of the control group died after treatment, the case fatality rate was 14.00%; the case fatality rate of the study group was lower than that of the control group, and there was significant difference between the two groups (χ2-4.891; P<0.05).


## 3.3. Comparison of NT-proBNP, PCT, and Ca2+ between the Two Groups after Treatment

NT-proBNP, PCT, and Ca2+ are important observation indexes in this study, so we compared NT-proBNP, PCT, and Ca2+ between the two groups. We compared the levels of NT-proBNP, PCT, and Ca2+ between the two groups after treatment. After treatment, the levels of NT-proBNP and PCT in the study group were significantly lower than those in the control group, and the content of serum Ca2+ in the study group was significantly higher than that in the control group. All the data results are shown in Table 2.Table 2
Comparison of NT-proBNP, PCT, and Ca2+ after treatment x¯±s.
GroupNNT-proBNP (ng/L)PCT (μg/L)Serum Ca2+ (mmol/L)C group501722.53 ± 198.4114.52 ± 3.201.42 ± 0.45R group501057.47 ± 165.607.38 ± 2.322.23 ± 0.72t18.19712.7736.746P0.0000.0000.000


## 3.4. Comparison of White Blood Cell Count and Neutrophil Ratio

We compared the white blood cell count and neutrophil ratio, and there was no significant difference between the two groups before treatmentP>0.05. The white blood cell count and neutrophil ratio in the study group were lower than those in the control group, and the difference was statistically significant P<0.05. The white blood cell count and the proportion of neutrophils in the study group were significantly lower than those in the control group P<0.05. All the data results are shown in Table 3.Table 3
Comparison of leukocyte count and neutrophil ratio B before and after treatment [x¯±s, Points].
GroupNWhite blood cell count (×109/L)Neutrophil ratio (%)Before treatmentAfter treatmentBefore treatmentAfter treatmentC group5022.63 ± 2.1217.45 ± 1.36a81.56 ± 2.7477.82 ± 1.44aR group5022.46 ± 2.1413.76 ± 1.28b81.17 ± 2.5673.48 ± 1.23bt0.39913.9710.73516.205P0.6910.0000.4640.000Note. the control group before and after treatment, aP<0.05; the study group before and after treatment, bP<0.05.


## 3.5. Comparison of Blood Coagulation Function Indexes between the Two Groups before and after Treatment

We compared the indexes of blood coagulation function between the two groups before and after treatment. Before treatment, there was no significant difference in the levels of APTT, PT, FIB, and DD between the two groups. After treatment, the levels of APTT, PT, and DD in the two groups decreased continuously, while the levels of FIB increased. Compared with the control group, the levels of APTT, PT, and DD in the study group were lower than those in the control group, while the level of FIB in the study group was higher than that in the control groupP<0.05. All the data are shown in Table 4.Table 4
Comparison of blood coagulation function indexes between the two groups before and after treatments (x¯±s, n = 50).
GroupAPTT (s)PT (s)FIB (g/L)DD (μg/L)Before treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatmentC group46.15 ± 9.4142.42 ± 8.44a14.97 ± 3.6213.29 ± 2.71a1.85 ± 0.432.56 ± 0.53a1354.59 ± 420.621024.47 ± 308.08aR group46.34 ± 9.3638.25 ± 8.37b14.37 ± 3.5612.18 ± 2.30b1.79 ± 0.543.78 ± 0.44b1350.55 ± 417.57790.33 ± 310.24bt Value0.1012.4810.8362.2080.61512.5240.0423.787P value0.9200.0150.4050.0300.5400.0000.9620.000Note. the control group before and after treatment, aP<0.05; the study group before and after treatment, bP<0.05.


## 3.6. Comparison of Blood Gas Analysis and APACHE-II Score between the Two Groups before and after Treatment

We compared the blood gas analysis and APACHE-II score between the two groups before and after treatment. There was no significant difference in partial pressure of oxygen (PaO2), oxygenation index (PaO2/FiO2), and APACHE-II score between the two groups before treatment. Compared with those before treatment, PaO2 and (PaO2/FiO2) increased and APACHE-II score decreased in both groups after treatment. Compared with the control group, PaO2 and PaO2/FiO2 were significantly higher and APACHE-II scores were lower in the treatment group after treatment. All the data are shown in Table 5.Table 5
Comparison of blood gas analysis and APACHE-II score before and after treatment (x¯±s, n = 50).
GroupPaO2 (mmHg)PaO2/FiO2APACHE-II Scoring (Points)Before treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatmentC group72.41 ± 12.0591.44 ± 10.30a206.55 ± 22.58313.55 ± 25.37a23.46 ± 3.3117.58 ± 3.11aR group72.38 ± 12.1196.82 ± 10.29b207.43 ± 23.15342.72 ± 26.10b23.50 ± 3.4213.37 ± 2.85bt0.0122.6130.1925.6670.0597.057P0.9900.0100.8480.0000.9530.000Note. the control group before and after treatment, aP<0.05; the study group before and after treatment, bP<0.05.


## 4. Discussion

Sepsis is an important contributor of septic shock and multiple organ dysfunction syndrome (MODS), which has become one of the important causes of death in critically ill patients due to its ferocious attack, rapid progress, and high mortality [10]. With the environmental pollution induced by the rapid development of society, the aging population, the increase of invasive diagnosis and treatment, and the extensive use of antibiotics bring about the increase of drug-resistant pathogenic microorganisms and patients with immune dysfunction, the incidence of severe sepsis is increasing year by year [9]. The condition of severe sepsis is often very critical, which can promote a serious blow to multiple organs of patients, and the mortality rate of patients is high [11]. Western medicine mainly explains the disease from the perspective of inflammation, a variety of reasons lead to inflammatory response in patients, excessive inflammation can exert damage to multiple organs of patients [12]. Some study reported that the blood leukocyte content of patients with sepsis can reach several times of the normal value, and all kinds of inflammatory factors increase massively, which can damage vascular endothelial cells, change vascular permeability, and disrupt the internal and external environment of blood vessels [13]. Other studies have suggested that inflammation can lead to local capillary thrombosis, multiple organ microthromboembolism can lead to organ failure, and patients may die of systemic multiple organ failure. CVVH is a commonly used renal replacement therapy in critically ill fields, which helps to stabilize the internal environment, regulate the balance of water and water, improve hemodynamic indexes, and inhibit the further development of inflammatory reactions reduce organ damage [13]. Traditional Chinese medicine believes that the sepsis belongs to the category of “febrile disease.” The patient feels evil poison externally, and the body defense qi is not enough to cause the evil toxin to invade the viscera from the outside to the inside; the internal toxin of the viscera grows so that the internal and external organs are trapped, the organs are trapped and lose their duty, and the meridian loses its qi and stasis, leading to febrile disease [14–16]. Xuebijing is a pure traditional Chinese medicine preparation, which is composed of safflower, Radix Paeoniae Chuanxiong, Angelica sinensis, and Salvia miltiorrhiza. Its active ingredients mainly include danshensu, paeoniflorin, and ferulic acid, which can activate blood circulation and remove blood stasis, dredge channels and collaterals, and disperse toxin [7]. Among them, Danshensu and paeoniflorin can improve tissue ischemia/reperfusion injury and scavenge oxygen free radicals, and ferulic acid has a strong promoting effect on nonspecific immunity, humoral immunity, and cellular immunity [17]. Its possible mechanism is to effectively antagonize endotoxin [18], downregulate the level of pro-inflammatory mediators, prevent the toxic damage of platelets and leukocytes, protect vascular endothelium from releasing prostacyclin normally, and reduce the damage of cell ultrastructure, preventing the occurrence of disorder of blood coagulation mechanism and disturbance of microcirculation [18].In this study, CVVH was performed in the control group, and Xuebijing was combined with Xuebijing in the study group. The results showed that the total effective rate of the study group was higher than that of the control group, and the difference was statistically significantP<0.05. Compare the case fatality rate between the two groups: 1 case died after treatment in the study group, the case fatality rate was 2.00%; 7 cases died in the control group after treatment, the case fatality rate was 14.00%; the case fatality rate in the study group was lower than that in the control group, and the difference between the two groups was statistically significant P<0.05. The analysis shows that CVVH combined with Xuebijing can not only improve the therapeutic effect of severe sepsis, but also reduce the mortality of patients. Some study found that Xuebijing can quickly reduce the amount of blood bacteria in patients, and the amount of blood bacteria in patients decreased by 97% after one week of medication, which is related to the fact that the drug contains a variety of antibacterial ingredients [19]. Some scholars have found that Xuebijing can inhibit the contents of IL-4, IL-6, and other cytokines in patients, truncate part of the anyway reaction process, stabilize the strong immune response in patients, and protect patients’ microvessels. On the other hand, hemoperfusion technology is widely used in clinic at present, which means that the blood is introduced into the container containing adsorbents through extracorporeal circulation, so that the toxic substances, inflammatory mediators, and metabolic wastes in the blood can be removed. CVVH can restore the immune balance of the body by reducing the inflammatory mediators in the body, block the inflammatory reaction, and reduce the damage to the organs of the body [9].Notably, the condition of severe sepsis is often very critical, which can cause a serious blow to multiple organs of patients, and the mortality rate of patients is high [20]. Western medicine mainly explains the disease from the perspective of inflammation, a variety of reasons lead to inflammatory waterfall reaction in patients, and excessive inflammatory response can cause damage to multiple organs of patients. The study found that the content of white blood cells in patients with sepsis can reach several times of the normal value, and all kinds of inflammatory factors increase massively, which can damage vascular endothelial cells, change vascular permeability, and disrupt the internal and external environment of blood vessels. Other studies have suggested that inflammation can lead to local capillary thrombosis, multi-organ microthromboembolism can lead to organ failure, and patients can die due to systemic multiple organ failure. Combined with the results of this study, the NT-proBNP and PCT of the study group were lower than those of the control group, and the serum Ca2+ of the study group was higher than that of the control group. The analysis shows that the lower the value of N-terminal B-type natriuretic peptide is, the more serious the disease is, which indicates that Xuebijing can reduce the intensity of inflammatory reaction, and the control of abnormal inflammatory response is beneficial to the protection of patients’ organs and reduce the occurrence of organ failure caused by inflammation. Xuebijing can relieve the degree of electrolyte disorder in patients with sepsis, stabilize the hemodynamics of patients, and avoid sharp fluctuations of electrolytes. In addition, in this study, there was no significant difference in white blood cell count and neutrophil ratio between the two groups before treatment P>0.05, but after treatment, white blood cell count and neutrophil ratio decreased in both groups. The white blood cell count and neutrophil count in the study group were lower than those in the control group P<0.05.The related research results show that the dysfunction of coagulation system plays an important role in the pathogenesis of sepsis [21]. When the pathological process of sepsis is normal, the coagulation, anticoagulation, and fibrinolysis systems are in a state of dynamic balance, while platelets and vascular endothelial cells are also involved to keep the blood unobstructed. During sepsis, the body releases a large number of inflammatory mediators, inhibiting fibrinolytic system and physiological anticoagulation system; on the contrary, coagulation system is activated, and coagulation activation promotes the further development of inflammatory response, which promotes each other and forms a vicious circle, leading to severe sepsis, septic shock, and multiple organ dysfunction syndrome [22]. Combined with the results of this study, there was no significant difference in the levels of APTT, PT, FIB, and DD between the two groups before treatment, but the levels of APTT, PT, and DD in the two groups decreased continuously after treatment., while FIB increased, and the levels of APTT, PT, and DD in the study group were lower than those in the control group, while the level of FIB in the study group was higher than that in the control group. The analysis shows that CVVH combined with Xuebijing can prevent platelet agglutination and destruction, hinder the formation of prothrombin kinase, prevent prothrombin from turning into thrombin, and inhibit thrombin, thus preventing FIB from becoming fibrin. CVVH mainly removes solutes with small and medium molecular weights by convection, while some middle and large molecular solutes can be adsorbed through the filter membrane, but it is greatly limited because the amount of removal depends on the adsorption capacity of the membrane. In addition, studies can also show that the changes of blood coagulation and inflammation are closely related to the severity and mortality of sepsis. Platelets can regulate vascular tension and stabilize the function of endothelial cells, which plays an important role in the occurrence and development of coagulation disorder in sepsis.Studies have shown that the lung is the first organ to fail in multiple organ dysfunction caused by sepsis, and sepsis is closely related to acute lung injury or acute respiratory distress syndrome [23–26]. The study found that early arterial blood gas analysis plays an important role in judging the prognosis of patients with sepsis. Combined with the results of this study, there was no significant difference in partial pressure of oxygen (PaO2), oxygenation index (PaO2/FiO2), and APACHE-II score between the two groups before treatment. Compared with those before treatment, PaO2 and (PaO2/FiO2) increased and APACHE-II score decreased in both groups after treatment [27–31]. Compared with the control group, PaO2 and PaO2/FiO2 in the treatment group after treatment were higher than those in the control group, while the APACHE-II score in the study group was lower than that in the control group after treatment. The analysis shows that the main mechanism of hypoxemia is lung injury caused by sepsis. The core of its pathogenesis is the recruitment and activation of inflammatory cells in lung tissue, resulting in damage to pulmonary capillary endothelial cells and alveolar epithelial cells, increased permeability of alveolar capillary membrane to water and protein, disturbance of fluid exchange between pulmonary vessels and stroma, and osmotic pulmonary edema in severe patients.


## 5. Conclusion

A case-control study was conducted to evaluate efficacy of the continuous veno-venous hemofiltration (CVVH) combined with Xuebijing in the treatment of severe sepsis. To check or verify this claim, a total of 100 patients with severe sepsis treated in our hospital, specifically from February 2019 to April 2021, were enrolled in this study. The patients were randomly divided into the control group and the study group. The control group was treated with CVVH, and the study group was treated with CVVH combined with Xuebijing. The therapeutic effect and mortality, NT-proBNP, PCT and Ca2+, white blood cell count, neutrophil ratio, blood gas analysis, and APACHE-II score were compared between the two groups. There was no statistical difference in baseline clinical data between the two kinds of patients. In the comparison of the treatment effects between the two groups, there were 27 cases of markedly effective, 22 cases of effective, and 1 case of ineffective in the study group, and the total effective rate was 98%; in the control group, 15 cases were markedly effective, 28 cases were effective, and 13 cases were ineffective, and the total effective rate was 86% P<0.05. CVVH combined with Xuebijing has positive significance in the treatment of patients with severe sepsis. After treatment, the coagulation function and blood gas indexes of the patients were significantly improved, the APACHE-II score decreased more significantly, and the white blood cell count and the proportion of neutrophils decreased. CVVH combined with Xuebijing has great clinical potential in the treatment of severe septic infection.



---

*Source: 7884508-2022-05-28.xml*